5U

Genertec Universal Medical Group Co LtdFRA Genertec Universal Stock Report

Last reporting period 30 Jun, 2024

Updated 12 Nov, 2024

Last price

Market cap $B

1.132

Small

Exchange

XFRA - Deutsche Boerse AG

5UM.F Stock Analysis

5U

Uncovered

Genertec Universal Medical Group Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

45/100

Low score

Market cap $B

1.132

Dividend yield

7.64 %

Shares outstanding

1 891.54 B

Genertec Universal Medical Group Co., Ltd. engages in the provision of healthcare services. The company is headquartered in Beijing, Beijing and currently employs 18,077 full-time employees. The company went IPO on 2015-07-08. The firm mainly operates through two segments. The Finance and Advisory Business segment mainly includes direct finance leasing, sale and leaseback, factoring, operating leases and advisory services. The Hospital Group Business segment mainly includes comprehensive medical services, hospital operation management, and import and export trade and domestic trade of medical-related goods. The firm mainly conducts business in China.

View Section: Eyestock Rating